In response to stricter FDA regulations, Well Health Research regretfully announces the cessation of all sales operations in the United States. This decision necessitates the relocation of our production and warehousing facilities to Canada. While Canada will serve as our primary base, we are actively exploring more flexible European jurisdictions. It's important to note that our legal address and consulting services will continue to operate in the U.S., providing ongoing support to our valued clients.
We remain committed to upholding the highest standards of quality and regulatory compliance as we navigate this transition. Well Health Research is dedicated to its mission of advancing health through innovative research and products. These adjustments are crucial to ensure our continued success and sustainability.